Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2010
03/03/2010EP1531875B1 Active agent delivery system including a poly(ethylene-co-(meth)acrylate), medical device, and method
03/03/2010EP1424973B1 Disposal system for transdermal dosage form
03/03/2010EP1404372B1 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1
03/03/2010EP0712431B1 PRESSURE SENSITIVE ADHESIVE COMPOSITION WHICH IS WATER DISPERSIBLE UNDER ALKALINE pH CONDITIONS
03/03/2010CN101663027A Solid dosage forms comprising an enteric coating with accelerated drug release
03/03/2010CN101663026A phenylalkyl carbamate compositions
03/03/2010CN101663025A Stabilised pharmaceutical composition containing pregabaline
03/03/2010CN101663024A Packaged film dosage unit containing a complexate
03/03/2010CN101663023A Process for dosing self-emulsifying drug delivery systems
03/03/2010CN101663022A topical pharmaceutical formulation
03/03/2010CN101658512A Adhesive patch
03/03/2010CN101658511A Adhesive patch
03/03/2010CN101658510A Coenzyme Q10 self-emulsifying microcapsules and preparation method thereof
03/03/2010CN101658509A Lansoprazole enteric-coated tablet and preparation method thereof
03/03/2010CN101658508A Novel enteric controlled-release tablet preparation and preparation method thereof
03/03/2010CN101658507A Glyceryl guaiacolate and pseudoephedrine compound sustained release preparation
03/03/2010CN101658506A Lovastatin nicotinic acid slow-release tablets and preparation method thereof
03/03/2010CN101658505A Sustained-release preparation of uloric and preparation method thereof
03/03/2010CN101658504A Paracetamol sustained-release double-layer tablets and preparation method thereof
03/03/2010CN101658503A Dihydroergotoxine sustained-release tablets and preparation process thereof
03/03/2010CN101658502A Metronidazole sustained-release tablets and preparation method thereof
03/03/2010CN101658501A Minocycline hydroehloride sustained- release tablets and preparation method thereof
03/03/2010CN101658500A Dextromethorphan hydrobromide sustained- release tablets and preparation method thereof
03/03/2010CN101658499A Preparation method of freeze-dried resveratrol albumin powder
03/03/2010CN101658498A Freeze-drying manufactured product of cytidine triphosphate disodium and arginine and preparation method thereof
03/03/2010CN101658497A Dual drug-loading composite microsphere and preparation method thereof
03/03/2010CN101658496A Exenatide release microsphere preparation, preparation method and application thereof
03/03/2010CN101658495A Hydrobromic acid lappaconitine solid lipid nano particle and preparation method thereof
03/03/2010CN101658494A Huperzine A solid lipid nano particle and preparation method thereof
03/03/2010CN101658493A Azithromycin nanostructured lipid carrier and preparation method thereof
03/03/2010CN101658492A Cefliofur injection and preparation method thereof
03/03/2010CN101658491A Amnion eye drops for curing cornea alkali burn
03/03/2010CN101658490A Preparation method of ropivacaine mesylate injection packed by soda-lime glass bottle
03/03/2010CN101658489A Nalmefene hydrochloride injection and preparation method thereof
03/03/2010CN101658488A Nalmefene hydrochloride injection and preparation method thereof
03/03/2010CN101658487A Glimepiride aqueous solution administration system and preparation method thereof
03/03/2010CN101658486A Hydrous external preparation containing sodium loxoprofen
03/03/2010CN101658485A Nanometer hybridized hydrogel with durable broad spectrum antibacterial performance and preparation method thereof
03/03/2010CN101658484A Preparation method and application of chitosan copolymer carrier micelle modified by cholesterol formyl chloride
03/03/2010CN101658483A Anti-cancer medicine slow release injection carrying bendamustine and potentiating agent of thereof
03/03/2010CN101658482A Low molecular chondroitin sulfate oral preparation, preparation method thereof and use thereof
03/03/2010CN101658481A Lercanidipine hydrochloride sustained release preparation and preparation method thereof
03/03/2010CN100592921C Activatable particles, preparations and uses.
03/03/2010CN100592920C Auxiliary materials of drop pills base material and manufacturing method of drop pills
03/03/2010CN100592919C Spray for treating chronic pharyngitis
03/03/2010CN100592916C Chinese medicine composition for treating lithiasis and preparation thereof
03/03/2010CN100592909C Dosage form of sodium ibuprofen
03/03/2010CN100592908C Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin
03/03/2010CN100592904C Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof
03/03/2010CN100592903C Stabilized natural cannabinoid formulation and preparation method thereof
03/02/2010USRE41157 Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
03/02/2010US7672726 System and method for controlling an implantable medical device subject to magnetic field or radio frequency exposure
03/02/2010US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents
03/02/2010US7671101 Gelled biopolymer based foam
03/02/2010US7671100 Controlled release delivery system of a soft, pliable dried gelled foams with high absorbancy comprise a crosslinked biopolymer such as alginate, optional foaming agent such as hydroxypropyl methyl cellulose, and a plasticizer such as glycerin or sorbitol; drug delivery, cosmetics
03/02/2010US7671093 Mixed co-crystals and pharmaceutical compositions comprising the same
03/02/2010US7671070 For therapy of ophthalmic, otic and nasal infections, particularly bacterial infections; conjunctivitis treatment with moxifloxacin hydrochloride
03/02/2010US7671042 Pharmaceutical compositions containing cyclodextrins and taxoids
03/02/2010US7671033 Amphiphilic dendritic dipeptides and their self-assembly into helical pores
03/02/2010US7671014 delivering carrier matrix to target site within patient by wetting components with fluid to create viscous aggregate comprising BMP-2 and bulking material selected from collagen-ceramic composites, allograft and bio-compatible ceramics or minerals that provide bone ingrowth scaffold, injecting into site
03/02/2010US7670627 Free-flowing powder encapsulated in pH sensitive microspheres
03/02/2010US7670626 Encapsulated bioactive bisphosphonate such as alendronate including mono- or diglyceride of caproic or capric acid enhancer or surfactant comprising ethylene oxide-propylene oxide block copolymer
03/02/2010US7670625 Pharmaceutical composition containing an active ingredient and a micronised carrier/diluent
03/02/2010US7670624 Provides site-specific release of drug to both small intestine and colon in form of multiple controlled doses for long-lasting efficacy, thereby reducing drug dosing frequency; drug core comprising first drug and saccharide coated by organic acid-soluble polymer, enteric coating polymer and second drug
03/02/2010US7670623 Hemostatic composition
03/02/2010US7670622 Composition for in vivo vessel repair
03/02/2010US7670621 A device for delivering fesoterodine (fumarate) through the skin in a dosage ofo.r-20 mg per day and is provided in a polymer matrix for uniform release;contact adhesives; sel-adhesives; impermeable backing; flatness; geratrics;drug delivery; side effect reduction
03/02/2010US7670619 A bilayer tablet for the treating of nervous system disorders associated with serotonin deficiencies having a rapid-release layer of 5-hydroxytryptophan and a slow-release layer of tryptophan or 5-hydroxytryptophan; physiological conditions; side effect reduction
03/02/2010US7670618 Pharmaceutical compositions
03/02/2010US7670617 Sequential drug delivery systems
03/02/2010US7670613 Androgen modulators
03/02/2010US7670612 Supplying active materials in various phases in single dosage multicompartment capsule
03/02/2010US7670606 Method for administering a vaginal care composition
03/02/2010US7670592 Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same
03/01/2010CA2640879A1 Liquid formulation containing a taxane derivative
02/2010
02/25/2010WO2010022364A1 Water soluble drugs and supplements
02/25/2010WO2010022293A2 Methods of processing compositions containing microparticles
02/25/2010WO2010022282A1 Methods of processing microparticles
02/25/2010WO2010022261A1 Methods of processing compositions containing microparticles
02/25/2010WO2010022193A2 Hot-melt extrusion of modified release multi-particulates
02/25/2010WO2010022031A1 Topical hydrogel composition
02/25/2010WO2010021973A2 Controlled delivery of bioactive agents from decomposable films
02/25/2010WO2010021942A1 Systems and devices for generating nitric oxide
02/25/2010WO2010021770A1 Heterogeneous polymeric micelles for intracellular delivery
02/25/2010WO2010021636A1 Corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
02/25/2010WO2010021617A1 Continuous spray scalp therapy and dispensing systems for same
02/25/2010WO2010021609A1 Solubility and stability enhancing pharmaceutical formulation
02/25/2010WO2010021608A1 Solubility enhancing pharmaceutical formulation
02/25/2010WO2010021389A1 Nucleic acid capable of inhibiting expression of bcl-2 protein
02/25/2010WO2010021320A1 Apparatus for producing vesicles having even diameters and process for producing the vesicles
02/25/2010WO2010021300A1 Novel excipient for mannitol tableting
02/25/2010WO2010020978A1 Methods and compositions for oral administration of proteins
02/25/2010WO2010020970A1 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof
02/25/2010WO2010020969A1 An extended release pharmaceutical composition of entacapone or salts thereof
02/25/2010WO2010020799A2 Composition
02/25/2010WO2010020794A1 Lipid formulations comprising a thiolated antioxidant
02/25/2010WO2010020772A2 Improvements in or relating to compositions
02/25/2010WO2010020098A1 Gastric retention drug delivery system, preparation method and use thereof
02/25/2010WO2010002712A3 Method of crystallization
02/25/2010WO2009155626A3 Functionally intact virus-inactivated fibrinogen remaining stable during storage
1 ... 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 ... 2991